Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2021-11-01 Sale |
2021-11-03 4:11 pm |
Merck & Co. Inc. | MRK | Gerberding Julie L. EVP, Chief Patient Officer |
96,270 | $87.91 | $8,462,682 | 71,691 (Direct) |
View |
| 2020-07-17 Sale |
2020-07-20 4:53 pm |
Merck & Co. Inc. | MRK | Gerberding Julie L. EVP Strat Comm, GI Pub Policy |
36,285 | $80 | $2,902,976 | 26,577 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-02-07 Option Award |
2025-02-10 3:08 pm |
N/A N/A |
MCKESSON CORP | MCK | Gerberding Julie L. Director |
176 | $0 | 176 (Direct) |
View |
| 2023-06-07 Option Award |
2023-06-09 6:41 pm |
N/A 2033-06-06 |
HilleVax Inc. | HLVX | Gerberding Julie L. Director |
22,500 | $0 | 22,500 (Direct) |
View |
| 2022-08-19 Option Award |
2022-08-23 4:36 pm |
N/A 2032-08-18 |
HilleVax Inc. | HLVX | Gerberding Julie L. Director |
25,000 | $0 | 25,000 (Direct) |
View |
| 2022-06-07 Equity Swap |
2022-06-09 5:24 pm |
N/A N/A |
CERNER Corp | CERN | Gerberding Julie L. Director |
15,032 | $95 | 0 (Direct) |
View |
Ownership |
2022-04-28 9:45 pm |
N/A N/A |
HilleVax Inc. | HLVX | Gerberding Julie L. Director |
0 | $0 | 42,025 (Direct) |
View |
| 2022-02-24 Option Award |
2022-02-28 4:17 pm |
N/A N/A |
Merck & Co. Inc. | MRK | Gerberding Julie L. EVP, Chief Patient Officer |
9,550 | $73.51 | 48,712 (Direct) |
View |
| 2021-11-01 Exercise |
2021-11-03 4:11 pm |
2018-05-05 2027-05-04 |
Merck & Co. Inc. | MRK | Gerberding Julie L. EVP, Chief Patient Officer |
96,270 | $0 | 71,691 (Direct) |
View |
Ownership |
2021-08-11 8:16 pm |
N/A N/A |
AfterNext HealthTech Acquisition Corp. | AFTR | Gerberding Julie L. Director |
0 | $0 | 40,000 (Direct) |
View |
| 2021-05-19 Option Award |
2021-05-20 5:29 pm |
N/A N/A |
CERNER Corp | CERN | Gerberding Julie L. Director |
3,188 | $0 | 15,032 (Direct) |
View |
| 2021-05-04 Option Award |
2021-05-06 4:43 pm |
2022-05-04 2031-05-03 |
Merck & Co. Inc. | MRK | Gerberding Julie L. EVP Strat Comm, GI Pub Policy |
39,796 | $0 | 78,958 (Direct) |
View |
| 2021-02-26 Option Award |
2021-03-02 11:46 am |
N/A N/A |
Merck & Co. Inc. | MRK | Gerberding Julie L. EVP Strat Comm, GI Pub Policy |
12,585 | $72.62 | 39,162 (Direct) |
View |
| 2020-07-17 Exercise |
2020-07-20 4:53 pm |
2017-05-10 2026-05-09 |
Merck & Co. Inc. | MRK | Gerberding Julie L. EVP Strat Comm, GI Pub Policy |
18,111 | $0 | 26,577 (Direct) |
View |
| 2020-05-22 Option Award |
2020-05-27 4:12 pm |
N/A N/A |
CERNER Corp | CERN | Gerberding Julie L. Director |
3,716 | $0 | 11,844 (Direct) |
View |
| 2020-05-01 Option Award |
2020-05-05 4:45 pm |
2021-05-01 2030-04-30 |
Merck & Co. Inc. | MRK | Gerberding Julie L. EVP Strat Comm, GI Pub Policy |
33,226 | $0 | 77,977 (Direct) |
View |